Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 6Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 4Breast Neoplasms 3Lung Neoplasms 2Colorectal Neoplasms 2Uterine Cervical Diseases 1Squamous Intraepithelial Lesions 1Smoking 1Postural Orthostatic Tachycardia Syndrome 1Papillomavirus Infections 1Pancreatic carcinoma, familial 1Pancreatic cancer, adult 1Mastocytosis 1Lung Cancer Screening 1Leukemia, Myelomonocytic, Chronic 1HIV Infections 1Disease 1Cervical Cancer Screening 1Bronchopulmonary Disease 1

Interventions

Bevacizumab 77Fluorouracil 55Cetuximab 48Oxaliplatin 43Leucovorin 42pembrolizumab 37Irinotecan 33Folfox protocol 24Capecitabine 24HMPL-013 22Specimen Handling 19trifluridine tipiracil drug combination 17Panitumumab 15Blood Specimen Collection 15Nivolumab 14Magnetic Resonance Spectroscopy 14regorafenib 13Biopsy 13Trifluridine 12Gemcitabine 12Cisplatin 12Standard of Care 11sintilimab 10Interviews as Topic 10IFL protocol 10Drug Therapy 10Carboplatin 10Cyclophosphamide 9tislelizumab 8Trastuzumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Colorectal Neoplasms × Mass Screening × Clear all
NCT06666192 2025-12-24

The Ohio State University (OSU) SCREEN Community Program

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
2,067 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Colorectal Neoplasms

NCT06612281 2024-11-14

Evaluation of Gixam's Performance in a FIT Negative Population

Jubaan Ltd.

Phase 2 Recruiting
400 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡